The present study aims to investigate the expression profiles of certain protein molecules in LNs of a sample of CRC patients, including integrin-linked kinase (ILK), vascular endothelial growth factor A (VEGFA), and ephrin type-A receptor 2 (EphA2), using immunohistochemical studies. This evidence concerns the gene ILK and colorectal carcinoma.